145 related articles for article (PubMed ID: 31176493)
1. Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma.
Okuda H; Ohnishi M; Takahashi H; Takagi C; Takada N; Ohashi T
Auris Nasus Larynx; 2019 Dec; 46(6):882-888. PubMed ID: 31176493
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of nedaplatin and S-1 treatment with concurrent radiotherapy in advanced head and neck cancer.
Hoshikawa H; Kishino T; Mori T; Indo K; Inamoto R; Akiyama K; Miyashita T; Mori N
Acta Otolaryngol; 2015 Jan; 135(1):103-8. PubMed ID: 25496182
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
Yamashita H; Haga A; Takenaka R; Kiritoshi T; Okuma K; Ohtomo K; Nakagawa K
Radiat Oncol; 2016 Jan; 11():4. PubMed ID: 26781439
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Ohashi T; Ohnishi M; Tanahashi S; Murai M
Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706).
Tahara M; Kiyota N; Mizusawa J; Nakamura K; Hayashi R; Akimoto T; Hasegawa Y; Iwae S; Monden N; Matsuura K; Fujii H; Onozawa Y; Homma A; Kubota A; Fukuda H; Fujii M
Cancer Sci; 2015 Jun; 106(6):726-733. PubMed ID: 25781202
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant chemotherapy (nedaplatin/UFT) after concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma].
Kubota A; Furukawa M; Komatsu M; Hanamura H; Sugiyama M
Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):149-56. PubMed ID: 16615429
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of S-1 plus nedaplatin in patients with advanced/recurrent head and neck cancer.
Kogashiwa Y; Yamauchi K; Nagafuji H; Matsuda T; Tsubosaka T; Karaho T; Maruyama T; Kohno N
Chemotherapy; 2010; 56(6):453-8. PubMed ID: 21088397
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or Larynx.
Taguchi T; Takahashi M; Nishimura G; Shiono O; Komatsu M; Sano D; Sakuma Y; Tanigaki Y; Kubota A; Taguri M; Hata M; Oridate N
Jpn J Clin Oncol; 2014 Dec; 44(12):1158-63. PubMed ID: 25267992
[TBL] [Abstract][Full Text] [Related]
9. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
11. Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma.
Kim HR; Lee CG; Choi EC; Kim JH; Koh YW; Cho BC
Head Neck; 2016 Apr; 38 Suppl 1():E1653-9. PubMed ID: 26890965
[TBL] [Abstract][Full Text] [Related]
12. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
[TBL] [Abstract][Full Text] [Related]
13. [Clinical phase trial of concurrent chemoradiotherapy combined TS-1 and nedaplatin].
Takemura H; Kobayashi S; Katsuno M; Asano R; Morimoto M; Tachibana S; Kubota H; Iida M; Kadokura Y; Sanbe T
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2065-9. PubMed ID: 16352930
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy with capecitabine/cisplatin versus 5-fluorouracil/cisplatin in resectable laryngohypopharyngeal squamous cell carcinoma.
Ahn D; Sohn JH; Kim JH; Lee JE; Park SH; Kim JC
Ear Nose Throat J; 2016 Feb; 95(2):E34-42. PubMed ID: 26930342
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer.
Kodaira T; Fuwa N; Tachibana H; Hidano S
Anticancer Res; 2006; 26(3B):2265-8. PubMed ID: 16821599
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma.
Kim HS; Kim HR; Kim GM; Kim HS; Koh YW; Kim SH; Choi EC; Hong YK; Sung JH; Kim SM; Kim JH; Cho BC
Cancer Chemother Pharmacol; 2012 Oct; 70(4):539-46. PubMed ID: 22868340
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of concomitant therapy with S-1, CDGP, and radiation for laryngeal cancer].
Morimoto M; Takemura H; Yui T; Suzuki T; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1903-6. PubMed ID: 20948253
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of concurrent chemoradiotherapy with S-1 administered on alternate days for elderly patients with head and neck cancer.
Kogashiwa Y; Nagafuji H; Kohno N
Anticancer Res; 2012 Sep; 32(9):4035-40. PubMed ID: 22993356
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
[TBL] [Abstract][Full Text] [Related]
20. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
